True Vision MN’s Amgen AMGN Stock Holding History

True Vision MN’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,836	Closed	-$529K	–	94
2023 Q4	$529K	Buy	+1,836	New	+$500K	0.42%	46

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

True Vision MN's AMGN Position: Q1 2024 in Review

True Vision MN sold out of Amgen (AMGN) in Q1 2024, closing a stake of 1,836 shares — an estimated $529K sold.

True Vision MN first reported a position in AMGN in Q4 2023 and held it in 1 quarter. The position peaked at $529K in Q4 2023. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

True Vision MN reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
True Vision MN sold 1,836 Amgen shares in Q1 2024, an estimated $529K.
True Vision MN first reported a position in Amgen in Q4 2023 and held it in 1 quarter.
True Vision MN's Amgen position peaked at $529K in Q4 2023.
2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on True Vision MN's 13F filing for Q1 2024, filed 30 Apr 2024.